摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7'-amino-5-bromo-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d] pyrimidine]-6'-carbonitrile | 1226674-87-8

中文名称
——
中文别名
——
英文名称
7'-amino-5-bromo-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d] pyrimidine]-6'-carbonitrile
英文别名
7'-Amino-5-bromo-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydrospiro [indoline-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile;7'-amino-5-bromo-2,4'-dioxo-2'-sulfanylidenespiro[1H-indole-3,5'-1H-pyrano[2,3-d]pyrimidine]-6'-carbonitrile
7'-amino-5-bromo-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d] pyrimidine]-6'-carbonitrile化学式
CAS
1226674-87-8
化学式
C15H8BrN5O3S
mdl
——
分子量
418.23
InChiKey
VBUCTXSDLNGPQM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    25
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    161
  • 氢给体数:
    4
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    4,6-二羟基-2-巯基嘧啶5-溴靛红丙二腈三乙胺 作用下, 以76%的产率得到7'-amino-5-bromo-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d] pyrimidine]-6'-carbonitrile
    参考文献:
    名称:
    微波辅助一锅合成2-氨基-4H-色烯和螺吡喃并[2,3-d]嘧啶
    摘要:
    研究了一种方便有效的方法,该方法利用微波辅助的一锅合成反应通过芳族醛与丙二腈和萘酚的混合物反应合成4 H-苯并[ f ]色烯。研究了靛红与丙二腈,巴比妥酸和/或硫代巴比妥酸反应合成螺并吡喃并[2,3- d ]嘧啶。还通过芳族醛和丙二腈与各种试剂的反应检查了该方法的多功能性。
    DOI:
    10.1002/cjoc.201090041
点击查看最新优质反应信息

文献信息

  • Preparation of GO/SiO<sub>2</sub>/PEA as a new solid base catalyst for the green synthesis of some spirooxindole derivatives
    作者:Mahla Toorbaf、Leila Moradi
    DOI:10.1039/d1ra02850b
    日期:——
    Efficient and green one pot multi component synthesis of some spirooxindole derivatives in the presence of graphene oxide functionalized with 2-(1-piperazinyl) ethylamine (GO/SiO2/PEA) as a solid base catalyst was studied. GO/SiO2/PEA has been obtained through a two step reaction and characterized by Fourier transform infrared spectroscopy (FTIR), field emission scanning electron microscopy (FE-SEM)
    研究了在以 2-(1-哌嗪基) 乙胺 (GO/SiO2/PEA) 为固体碱催化剂功能化的氧化石墨烯存在下,高效、绿色地一锅法合成一些螺吲哚生物。GO/SiO2/PEA通过两步反应得到,并通过傅里叶变换红外光谱(FTIR)、场发射扫描电子显微镜(FE-SEM)、能量色散X射线光谱(EDX)、热重分析( TGA)、拉曼光谱和 X 射线衍射 (XRD)。绿色反应条件、短反应时间、可重复使用的催化剂和高至优异的产品产率是该方法的一些优势。
  • Oxalic acid dihydrate: proline as a new recyclable designer solvent: a sustainable, green avenue for the synthesis of spirooxindole
    作者:Dattatray R. Chandam、Abhijeet G. Mulik、Dayanand R. Patil、Madhukar B. Deshmukh
    DOI:10.1007/s11164-015-2093-3
    日期:2016.2
    encouraged to explore oxalic acid dihydrate: proline low transition temperature mixture as a new designer solvent for the said synthesis at room temperature. It has been successfully applied for the three component reaction of isatin, malononitrile or ethyl cyanoacetate and 1,3–dicarbonyl compounds for the first time. Moderate to good yield of the products, shorter reaction time, energy efficiency, chromatography-free
    摘要 为开发具有巨大生物活性的螺氧基吲哚生物的环保,可持续协议的要求鼓励了探索草酸二水合物:脯酸低转变温度混合物作为在室温下所述合成的新型设计溶剂。它已成功地首次用于靛红丙二腈乙酸乙酯与1,3-二羰基化合物的三组分反应。该产品具有中等至良好的收率,较短的反应时间,能源效率,无色谱纯化工艺,可回收性和高原子经济性是该协议的诱人特性,将在多组分,面向多样性的合成中得到应用。 图形概要
  • Synthetic, mechanistic and kinetic studies on the organo-nanocatalyzed synthesis of oxygen and nitrogen containing spiro compounds under ultrasonic conditions
    作者:Nongthombam Geetmani Singh、Makroni Lily、Shougaijam Premila Devi、Noimur Rahman、Aziz Ahmed、Asit K. Chandra、Rishanlang Nongkhlaw
    DOI:10.1039/c6gc00724d
    日期:——
    Vitamin B1 functionalised nano-ferrites: an organo-nanocatalyst for the synthesis of various spiro derivatives.
    维生素B 1官能化的纳米铁氧体:用于合成各种螺衍生物的有机纳米催化剂。
  • Zinc(II)‐poly(urea‐formaldehyde) supported on magnetic nanoparticles: A hybrid nanocatalyst for green synthesis of spiropyrans, spiroxanthenes, and spiropyrimidines
    作者:Mohammad Ali Bodaghifard、Zahra Mousavi
    DOI:10.1002/aoc.5859
    日期:2020.10
    Zinc‐poly(urea‐formaldehyde) supported on magnetic nanoparticles (MNPs@SiO2@PUF@Zn) was successfully used for the synthesis of spirooxindolopyran and spirooxindoloxanthene derivatives in aqueous medium as an environmentally benign condition. High yields, short reaction times, green solvent, reusability without significant reduction in catalytic activity, and simple separation of the catalyst using an external magnet
    属离子固定在无机载体上具有非常有趣的生物学,工业和催化应用。在这项研究中,通过将醋酸锌固定在磁性CoFe 2 O 4 @SiO 2上负载的聚甲醛表面上,成功制造了CoFe 2 O 4 @SiO 2 @ PUF @ Zn(OAc)2纳米结构。纳米颗粒通过一层一层的组装。杂化纳米颗粒的结构通过傅里叶变换红外光谱,X射线衍射,热重分析,能量色散X射线光谱,电感耦合等离子体原子发射光谱,振动样品磁力分析,Brunauer-Emmett-Teller表面积分析,扫描进行表征电子显微镜和透射电子显微镜。磁性纳米颗粒(MNPs @ SiO 2)上负载的-聚(醛)(PUF @ Zn)作为一种环境友好的条件,已成功地用于在性介质中合成螺并氧杂并喃和螺并恶多恶并生物。该方法的优点是高收率,较短的反应时间,绿色溶剂,可重用性而不会显着降低催化活性,使用外磁体简单地分离催化剂以及环境相容性。
  • Base free synthesis of iron oxide supported on boron nitride for the construction of highly functionalized pyrans and spirooxindoles
    作者:Aniruddha Molla、Sahid Hussain
    DOI:10.1039/c5ra21969h
    日期:——

    BN@Fe3O4 network was synthesized via chemical reduction followed by aerial oxidation in absence of base and was subsequently used for the synthesis of highly functionalized pyrans and spirooxindoles derivatives on water.

    BN@Fe3O4网络是通过化学还原后在无碱的条件下进行空气氧化合成的,并随后用于在中合成高度功能化的喃和螺环氧吲哚生物
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione